Are you attending a cell or gene therapy conference in 2023? Tell us about your research for a chance to win up to $500 USD toward your conference registration fee.
*The contest closes on June 6, 2023, and 2 winners will be picked randomly and contacted shortly afterward. The winner must provide proof of registration to the conference.
Contest closes on June 6, 2023, and the winners will be determined shortly thereafter. This contest is applicable to cell or gene therapy conferences that are held in 2023. The winners must provide proof of conference registration to receive their award. No purchase is necessary to enter or win. This promotion is open only to legal residents of Australia, Austria, Belgium, Canada, Denmark, Finland, Germany, Iceland, Ireland, Luxembourg, the Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland, the United Kingdom, and the United States, who are 18 years or older as of the date of entry and who must be able to accept the prize without violating the terms of their employment. Void where prohibited by law or institutional policy. STEMCELL reserves the right to seek verification of eligibility to enter and receive a prize under these rules. The winner will be compensated for their cost of conference registration, up to $500 USD, depending on their registration fee. Previous winners of the STEMCELL Travel or Conference Award Contests are not eligible to participate.
STEMCELL Technologies may release the winner’s name and reproduce the resulting content in educational, news, or promotional materials, whether in print, electronic, or other media, including on the STEMCELL website and social media platforms. By participating in this contest, you grant and assign to STEMCELL the right to use this content for such purposes.
This promotion and any matter arising from it shall be exclusively governed by the laws of British Columbia, Canada.
* Each winner will receive up to $500 USD of their registration fee or the cost of their registration fee, whichever is the lesser.